Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9904)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 14, 2018 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Oikonomou T, Papatheodoridis GV, Samarkos M, Goulis I, Cholongitas E. Clinical impact of microbiome in patients with decompensated cirrhosis. World J Gastroenterol 2018; 24(34): 3813-3820 [PMID: 30228776 DOI: 10.3748/wjg.v24.i34.3813] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i34/3813.htm |
| Number | Citing Articles |
| 1 |
Sundhar Mohandas, Balasubramaniyan Vairappan. Ginkgolide-A attenuates bacterial translocation through activating PXR and improving antimicrobial peptide Reg 3A in experimental cirrhosis. Life Sciences 2020; 257: 118111 doi: 10.1016/j.lfs.2020.118111
|
| 2 |
David U. Lee, Gregory H. Fan, David J. Hastie, Elyse A. Addonizio, Vibhav N. Prakasam, Ryan R. Ahern, Kristen J. Seog, Raffi Karagozian. The Impact of Malnutrition on the Hospital and Infectious Outcomes of Patients Admitted With Alcoholic Hepatitis. Journal of Clinical Gastroenterology 2022; 56(4): 349 doi: 10.1097/MCG.0000000000001528
|
| 3 |
Kazuhiko Ikeuchi, Takeya Tsutsumi, Aya Ishizaka, Taketoshi Mizutani, Ayako Sedohara, Michiko Koga, Satoru Tamaoki, Hiroshi Yotsuyanagi. Modulation of duodenal and jejunal microbiota by rifaximin in mice with CCl4-induced liver fibrosis. Gut Pathogens 2023; 15(1) doi: 10.1186/s13099-023-00541-4
|
| 4 |
Elisa Rubio Garcia, Andrea Vergara, Fátima Aziz, Sofía Narváez, Genoveva Cuesta, María Hernández, David Toapanta, Francesc Marco, Javier Fernández, Alex Soriano, Jordi Vila, Climent Casals-Pascual. Changes in the gut microbiota and risk of colonization by multidrug-resistant bacteria, infection, and death in critical care patients. Clinical Microbiology and Infection 2022; 28(7): 975 doi: 10.1016/j.cmi.2022.01.004
|
| 5 |
Ting Wang, Taichi Ishikawa, Minoru Sasaki, Toshimi Chiba. Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.822190
|
| 6 |
Alba Santiago, Elisabet Sanchez, Allison Clark, Marta Pozuelo, Miguel Calvo, Francisca Yañez, Guillaume Sarrabayrouse, Lidia Perea, Silvia Vidal, Alberto Gallardo, Carlos Guarner, German Soriano, Chaysavanh Manichanh, Catherine Lozupone. Sequential Changes in the Mesenteric Lymph Node Microbiome and Immune Response during Cirrhosis Induction in Rats. mSystems 2019; 4(1) doi: 10.1128/msystems.00278-18
|
| 7 |
Zuzanna Karwowska, Janusz Szemraj, Bolesław Karwowski. Microbiota Alterations in Gastrointestinal Cancers. Applied Sciences 2020; 10(2): 585 doi: 10.3390/app10020585
|
| 8 |
Mohadeseh Naseri, Hamidreza Houri, Abbas Yadegar, Hamid Asadzadeh Aghdaei, Javad Zahiri. Investigation of etiology-specific alterations in the gut microbiota in liver cirrhosis. Expert Review of Gastroenterology & Hepatology 2021; 15(12): 1435 doi: 10.1080/17474124.2021.1991312
|
| 9 |
Xiaoqiang Qi, Ming Yang, Joseph Stenberg, Rahul Dey, Leslie Fogwe, Muhammad Shawkat Alam, Eric T Kimchi, Kevin F Staveley-O'Carroll, Guangfu Li. Gut microbiota mediated molecular events and therapy in liver diseases. World Journal of Gastroenterology 2020; 26(48): 7603-7618 doi: 10.3748/wjg.v26.i48.7603
|
| 10 |
Yan-Chao Hu, Xiang-Chun Ding, Hui-Juan Liu, Wan-Long Ma, Xue-Yan Feng, Li-Na Ma. Effects of <i>Lactobacillus paracasei</i> N1115 on gut microbial imbalance and liver function in patients with hepatitis B-related cirrhosis. World Journal of Gastroenterology 2024; 30(11): 1556-1571 doi: 10.3748/wjg.v30.i11.1556
|
| 11 |
Daniel M. Chopyk, Arash Grakoui. Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders. Gastroenterology 2020; 159(3): 849 doi: 10.1053/j.gastro.2020.04.077
|
| 12 |
Ji-Won Park, Sung-Eun Kim, Na Young Lee, Jung-Hee Kim, Jang-Han Jung, Myoung-Kuk Jang, Sang-Hoon Park, Myung-Seok Lee, Dong-Joon Kim, Hyoung-Su Kim, Ki Tae Suk. Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases. International Journal of Molecular Sciences 2021; 23(1): 426 doi: 10.3390/ijms23010426
|
| 13 |
Shipeng Li, Wenfeng Han, Qichen He, Wei Zhang, Youcheng Zhang, Mohammad Farukh Hashmi. Relationship between Intestinal Microflora and Hepatocellular Cancer Based on Gut‐Liver Axis Theory. Contrast Media & Molecular Imaging 2022; 2022(1) doi: 10.1155/2022/6533628
|
| 14 |
Remo Poto, William Fusco, Emanuele Rinninella, Marco Cintoni, Francesco Kaitsas, Pauline Raoul, Cristiano Caruso, Maria Cristina Mele, Gilda Varricchi, Antonio Gasbarrini, Giovanni Cammarota, Gianluca Ianiro. The Role of Gut Microbiota and Leaky Gut in the Pathogenesis of Food Allergy. Nutrients 2023; 16(1): 92 doi: 10.3390/nu16010092
|
| 15 |
Ivana Milosevic, Ankica Vujovic, Aleksandra Barac, Marina Djelic, Milos Korac, Aleksandra Radovanovic Spurnic, Ivana Gmizic, Olja Stevanovic, Vladimir Djordjevic, Nebojsa Lekic, Edda Russo, Amedeo Amedei. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. International Journal of Molecular Sciences 2019; 20(2): 395 doi: 10.3390/ijms20020395
|
| 16 |
Mohadeseh Naseri, Fahimeh Palizban, Abbas Yadegar, Mohsen Khodarahmi, Hamid Asadzadeh Aghdaei, Hamidreza Houri, Javad Zahiri. Investigation and characterization of human gut phageome in advanced liver cirrhosis of defined etiologies. Gut Pathogens 2022; 14(1) doi: 10.1186/s13099-022-00482-4
|
| 17 |
Qi-Feng Gui, Hui-Lin Jin, Feng Zhu, Hai-Feng Lu, Qin Zhang, Jia Xu, Yun-Mei Yang, Chi Xiao. Gut microbiota signatures in Schistosoma japonicum infection-induced liver cirrhosis patients: a case–control study. Infectious Diseases of Poverty 2021; 10(1) doi: 10.1186/s40249-021-00821-8
|
| 18 |
Cyriac A. Philips, Philip Augustine. Gut Barrier and Microbiota in Cirrhosis. Journal of Clinical and Experimental Hepatology 2022; 12(2): 625 doi: 10.1016/j.jceh.2021.08.027
|
| 19 |
Amedeo Amedei, Stefano Gitto, Claudia Campani, Fabio Marra. Probiotics. 2022; : 467 doi: 10.1016/B978-0-323-85170-1.00003-8
|
| 20 |
Tongyao Wang, Xingyu Rong, Chao Zhao. Circadian Rhythms Coordinated With Gut Microbiota Partially Account for Individual Differences in Hepatitis B-Related Cirrhosis. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.936815
|
| 21 |
Fang Liu, Dan Su, Heng Zhang, Hong-Cheng Lin, Qian Zhou, Bo Cao, Dong-Lin Ren. Clinical implications of the oral‑gut microbiome axis and its association with colorectal cancer (Review). Oncology Reports 2022; 48(5) doi: 10.3892/or.2022.8407
|
| 22 |
Datao Lin, Qiuyue Song, Jiahua Liu, Fang Chen, Yishu Zhang, Zhongdao Wu, Xi Sun, Xiaoying Wu. Potential Gut Microbiota Features for Non-Invasive Detection of Schistosomiasis. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.941530
|
| 23 |
Jessica Ferguson Toll, Elsa Solà, Maria Alejandra Perez, Salvatore Piano, Alice Cheng, Aruna K. Subramanian, W. Ray Kim. Infections in decompensated cirrhosis: Pathophysiology, management, and research agenda. Hepatology Communications 2024; 8(10) doi: 10.1097/HC9.0000000000000539
|
| 24 |
Michael Camilleri. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut 2019; 68(8): 1516 doi: 10.1136/gutjnl-2019-318427
|
| 25 |
Yuanyuan Su, Ning Lu, Qian Li, Hua Wen, Xiao Qin Zhang, Mingxin Zhang, Jian Wu. Gut Microbiota and Drug-Related Liver Injury: Challenges and Perspectives. Advanced Gut & Microbiome Research 2023; 2023: 1 doi: 10.1155/2023/5442597
|
| 26 |
Long Huang, Qingsheng Yu, Hui Peng, Zhou Zhen. Alterations of gut microbiome and effects of probiotic therapy in patients with liver cirrhosis: A systematic review and meta-analysis. Medicine 2022; 101(51): e32335 doi: 10.1097/MD.0000000000032335
|
| 27 |
Jim Höppner, Sandra Krohn, Ellen H. A. van den Munckhof, René Kallies, Adam Herber, Katharina Zeller, Jan Tünnemann, Madlen Matz-Soja, Antonis Chatzinotas, Stephan Böhm, Albrecht Hoffmeister, Thomas Berg, Cornelius Engelmann. Changes of the bacterial composition in duodenal fluid from patients with liver cirrhosis and molecular bacterascites. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-49505-3
|